Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Danitracen

From Wikipedia, the free encyclopedia

Danitracen
Identifiers
  • 4-(6H-benzo[c][1]benzothiepin-11-ylidene)-1-methylpiperidine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H21NO
Molar mass291.394 g·mol−1
3D model (JSmol)
  • CN1CCC(=C2C3=CC=CC=C3C(C4=CC=CC=C42)O)CC1
  • InChI=1S/C20H21NO/c1-21-12-10-14(11-13-21)19-15-6-2-4-8-17(15)20(22)18-9-5-3-7-16(18)19/h2-9,20,22H,10-13H2,1H3
  • Key:HLBRHTFSMMEHPK-UHFFFAOYSA-N

Danitracen (WA 335) is an antidepressant compound developed in the 1970s. Danitracen acts by blocking central and peripheral 5-HT receptors: it potentiates testosterone-induced sexual behavior in rats and abolishes the 5-hydroxytryptophan (5-HTP) induced hypermotility in mice. In amphetamine-treated rats, administration of danitracen lowered whole brain serotonin and norepinephrine levels. Danitracen was investigated in clinical trials in depressed patients. At 3 mg/day, danitracen was equipotent to 150 mg/day amitriptyline.[1][2][3][4][5][6]

See also

[edit]

References

[edit]
  1. Engelhardt G (November 1975). "[On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist (author's transl)]". Arzneimittel-Forschung (in German). 25 (11): 1723–37. PMID 1049.
  2. "Danitracen". Inxight Drugs. National Center for Advancing Translational Sciences (NCATS).
  3. Castañer J, Chatterjee SS (1976). "Danitracen". Drugs of the Future. 1 (6)): 279. doi:10.1358/dof.1976.001.06.1002525.
  4. Maj J, Baran L, Sowińska H, Gancarczyk L (1976). "The action of compound WA-335 on the central nervous system". Archivum Immunologiae et Therapiae Experimentalis. 24 (2): 205–22. PMID 945051.
  5. Maj J, Sowińska H, Baran L (1976). "Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy". Archivum Immunologiae et Therapiae Experimentalis. 24 (2): 197–203. PMID 945050.
  6. Matussek N, Benkert O, Fidetzis K, Flach D, Hermann HU, Kaumeier S, et al. (1976). "[Comparison of the effects of the anthracene derivative danitracen (WA335-BS) and amitriptyline in depressive patients (author's transl)]". Arzneimittel-Forschung (in German). 26 (6): 1160–2. PMID 786311.

Attribution: some content on this page was copied from the public domain source https://drugs.ncats.io/drug/SD507F5T2W.